Molded polymer-coated composite bone void filler improves tobramycin controlled release kinetics

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 102, Issue 5, 2014, Pages 1074-1083

  Brooks, Benjamin D ^a   Sinclair, Kristofer D ^b   Davidoff, Sherry N ^c   Lawson, Scott ^c   Williams, Alex G ^c   Coats, Brittany ^c   Grainger, David W ^a,c   Brooks, Amanda E ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b Elute Inc   (United States)

^c Department of Electrical and Computer Engineering   (United States)

Author keywords

bone void filler; controlled release; implant infection; joint replacement; osteomyelitis; polycaprolactone; revision surgery; tobramycin

Indexed keywords

ANTIBIOTICS; BIOLOGICAL MATERIALS; BONE; FABRICATION; JOINT PROSTHESES; KINETICS; MECHANICAL PROPERTIES; POLYCAPROLACTONE; POLYMERS;

CONTROLLED RELEASE; IMPLANT INFECTIONS; JOINT REPLACEMENT; OSTEOMYELITIS; REVISION SURGERY; TOBRAMYCIN;

FILLERS;

BIOMATERIAL; CALCIUM CARBONATE; CALCIUM PHOSPHATE CERAMIC; MACROGOL; POLYCAPROLACTONE; POLYMER; TOBRAMYCIN SULFATE; ANTIINFECTIVE AGENT; BONE PROSTHESIS; CALCIUM PHOSPHATE; CERAMICS; DELAYED RELEASE FORMULATION; POLYESTER; TOBRAMYCIN;

ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BONE CONDUCTION; BONE FILLER; BONE REGENERATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; IN VITRO STUDY; KINETICS; MATERIAL COATING; NONHUMAN; QUALITY CONTROL; STAPHYLOCOCCUS AUREUS; BONE PROSTHESIS; CERAMICS; CHEMISTRY; DELAYED RELEASE FORMULATION; GROWTH, DEVELOPMENT AND AGING; PHARMACOKINETICS; PHARMACOLOGY;

ANTI-BACTERIAL AGENTS; BONE SUBSTITUTES; CALCIUM PHOSPHATES; CERAMICS; DELAYED-ACTION PREPARATIONS; POLYESTERS; STAPHYLOCOCCUS AUREUS; TOBRAMYCIN;

EID: 84902449399     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33089     Document Type: Article

References (43)

1. Jiranek WA, Hanssen AD, Greenwald AS,. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Jt Surg 2006; 88: 2487-2500. (Pubitemid 44713839)
2. Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ,. Future young patient demand for primary and revision joint replacement: National projections from 2010 to 2030. Clin Orthop 2009; 467: 2606-2612.
3. Conterno LO, da Silva Filho CR, Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev 2009; 3.
4. Landersdorfer CB, Bulitta JB, Kinzig M, Holzgrabe U, Sörgel F,. Penetration of antibacterials into bone. Clin Pharmacokinet 2009; 48: 2009.
5. Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J,. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 2012; 27: 61-65.e1.
6. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J,. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008; 23: 2008.
7. Brooks BD, Brooks AE, Grainger DW,. Antimicrobial medical devices in preclinical development and clinical use. In:, Moriarty TF, Zaat SAJ, Busscher HJ, editors. Biomaterials Associated Infection. New York: Springer; 2013. pp 307-354.
8. Richards RG, Moriarty TF, Miclau T, McClellan RT, Grainger DW,. Advances in biomaterials and surface technologies, J Orthop Trauma 2012; 26: 703-707.
9. Vasilev K, Cook J, Griesser HJ,. Antibacterial surfaces for biomedical devices. Expert Rev Med. Devices 2009; 6: 553-567.
10. Simchi A, Tamjid E, Pishbin F, Boccaccini AR,. Recent progress in inorganic and composite coatings with bactericidal capability for orthopaedic applications. Nanomed Nanotechnol Biol Med 2011; 7: 22-39.
11. Gunnam R,. The future of orthopedic implants analysis and forecasts to 2016. GBI Research, 2010.
12. Bostrom MP, Seigerman DA,. The clinical use of allografts, demineralized bone matrices, synthetic bone graft substitutes and osteoinductive growth factors: A survey study. HSS J 2005; 1: 9-18.
13. Giannoudis PV, Dinopoulos H, Tsiridis E,. Bone substitutes: An update. Injury 2005; 36: S20-S27.
14. Brooks AE, Brooks BD, Davidoff SN, Hogrebe PC, Fisher MA, Grainger DW,. Polymer-controlled release of tobramycin from bone graft void filler. Drug Deliv Transl Res 2013; 3: 518-530.
15. Nandi SK, Roy S, Mukherjee P, Kundu B, De DK, Basu D,. Orthopaedic applications of bone graft and graft substitutes: Indian J Med Res 2010; 132: 15-30.
16. Costerton JW,. The etiology and persistence of cryptic bacterial infections: A hypothesis. Clin Infect Dis 1984; 6: S608-S616.
17. Kanellakopoulou K, Giamarellos-Bourboulis EJ,. Carrier systems for the local delivery of antibiotics in bone infections. Drugs 2000; 59: 1223-1232. (Pubitemid 30410141)
18. Koort JK, Suokas E, Veiranto M, Mäkinen TJ, Jalava J, Törmälä P, Aro HT,. In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment. J Biomed Mater Res A 2006; 78: 532-540. (Pubitemid 44253537)
19. McKee MD, Wild LM, Schemitsch EH, Waddell JP,. The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: Early results of a prospective trial. J Orthop Trauma 2002; 16: 622-627. (Pubitemid 35214851)
20. Winkler H, Stoiber A, Kaudela K, Winter F, Menschik F,. One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg Br 2008; 90: 1580-1584.
21. Davidoff SN, Call BP, Hogrebe PC, Grainger DW, Brooks AE,. A robust method to coat allograft bone with a drug-releasing polymer shell-biomed 2010. Biomed Sci Instrum 2010; 46: 184.
22. Sevy JO, Slawson MH, Grainger DW, Brooks AE,. Assay method for polymer-controlled antibiotic release from allograft bone to target orthopaedic infections-biomed 2010. Biomed Sci Instrum 2010; 46: 136.
23. Garvin KL, Hinrichs SH, Urban JA,. Emerging antibiotic-resistant bacteria: Their treatment in total joint arthroplasty. Clin Orthop 1999; 369: 110-123.
24. Guide to the Elimination of Orthopedic Surgical Site Infections. APIC, 2010.
25. Brooks BD, Davidoff SN, Grainger DW, Brooks AE,. Comparisons of release of several antibiotics from antimicrobial polymer-coated allograft bone void filler. International Journal of Biomedical Materials Research. 2014 (In Press).
26. Mousset B, Benoit MA, Delloye C, Bouillet R, Gillard J,. Biodegradable implants for potential use in bone infection. Int Orthop 1995; 19: 157-161.
27. Begg EJ, Barclay ML,. Aminoglycosides - 50 years on. Br J Clin Pharmacol 1995; 39: 597-603.
28. Brandl M, Gu L,. Degradation of tobramycin in aqueous solution. Drug Dev Ind Pharm 1992; 18: 1423-1436.
29. Biewener AA, Taylor CR,. Bone strain: A determinant of gait and speed? J Exp Biol 1986; 123: 383-400. (Pubitemid 16071463)
30. Pulido L, Ghanem E, Ashish Joshi MPH, Purtill JJ,. Periprosthetic joint infection: The incidence, timing, predisposing factors. Clin Orthop 2008; 466: 1710-1715.
31. Bourne RB,. Prophylactic use of antibiotic bone cement: An emerging standard-in the affirmative1. J Arthroplasty 2004; 19: 69-72. (Pubitemid 38746720)
32. Terry AC, Quanjun C,. Antibiotic laden cement: Current state of the art. AAOS.
33. Schmidmaier G, Gahukamble AD, Moriarty TF, Richards RG,. Infection in fracture fixation: Device design and antibiotic coatings reduce infection rates. Moriarty TF et al (Eds) In Biomaterials Associated Infection: Immunological Aspects and Antimicrobial Strategies, Springer, 2013, pp. 435-453.
34. Wenke JC, Owens BD, Svoboda SJ, Brooks DE,. Effectiveness of commercially-available antibiotic-impregnated implants. J Bone Joint Surg Br 2006; 88: 1102-1104.
35. Winkler H, Kaudela K, Stoiber A, Menschik F,. Bone grafts impregnated with antibiotics as a tool for treating infected implants in orthopedic surgery-One stage revision results. Cell Tissue Bank 2006; 7: 319-323. (Pubitemid 44724555)
36. Witsø E, Persen L, Løseth K, Bergh K,. Adsorption and release of antibiotics from morselized cancellous bone. In vitro studies of 8 antibiotics. Acta Orthop Scand 1999; 70: 298-304. (Pubitemid 29327026)
37. Witsø E, Persen L, Løseth K, Benum P, Bergh K,. Cancellous bone as an antibiotic carrier. Acta Orthop Scand 2000; 71: 80-84. (Pubitemid 30150562)
38. Roberts JA, Kruger P, Paterson DL, Lipman J,. Antibiotic resistance-What's dosing got to do with it? Crit Care Med 2008; 36: 2433-2440.
39. Chuang WT, Jeng US, Sheu HS, Hong PD,. Competition between phase separation and crystallization in a PCL/PEG polymer blend captured by synchronized SAXS, WAXS, DSC. Macromol Res 2006; 14: 45-51.
40. Wei-Tsung Chuang KSS,. Kinetics of phase separation in poly(ε-caprolactone)/poly(ethylene glycol) blends. Journal of Polymer Research. 2005; 12 (3): 197-204. doi: 10.1007/s10965-004-1868-9.
41. Liu KL, Widjaja E, Huang Y, Ng XW, Loo SCJ, Boey FYC, Venkatraman SS,. A new insight for an old system: Protein-PEG colocalization in relation to protein release from PCL/PEG blends. Mol Pharm 2011; 8: 2173-2182.
42. Moore WR, Graves SE, Bain GI,. Synthetic bone graft substitutes. ANZ J Surgery 2001; 71: 354-361.
43. Van der Stok J, Van Lieshout EMM, El-Massoudi Y, Van Kralingen GH, Patka P,. Bone substitutes in the Netherlands-A systematic literature review. Acta Biomater 2011; 7: 739-750.